Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

BACKGROUND: The survival rate among patients with intermediate-risk neuroblastoma who receive dose-intensive chemotherapy is excellent, but the survival rate among patients who receive reduced doses of chemotherapy for shorter periods of time is not known. METHODS: We conducted a prospective, phase...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Baker, David L., Schmidt, Mary L., Cohn, Susan L., Maris, John M., London, Wendy B., Buxton, Allen, Stram, Daniel, Castleberry, Robert P., Shimada, Hiroyuki, Sandler, Anthony, Shamberger, Robert C., Look, A. Thomas, Reynolds, C. Patrick, Seeger, Robert C., Matthay, Katherine K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2993160/
https://ncbi.nlm.nih.gov/pubmed/20879880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1001527
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky